SRGN and osteosarcoma: Consistent with the mass-spectrum analysis, quantitative PCR (qPCR) and Western blotting assays showed that the mRNA expression and protein secretion of SRGN were much higher in GCTB stromal cells than in osteosarcoma cells (Fig. 1D, E).